References 1 Jobson, RW, Qiu, YL. Did RNA editing in plant organellar genomes originate under natural selection or through genetic drift? Biol Direct 2008, 3: 43.et al. Sequence requirements for the editing of apolipoprotein B mRNA. J Biol Chem 1991, 266: 16301–16304.et al. Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme‐complex. J Biol Chem 2000, 275: 19848–19856.et al. Complete phenotypic characterization of apobec‐1 knockout mice with a wild‐type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec‐1. J Biol Chem 1996, 271: 25981–25988.et al. Apolipoprotein B RNA editing enzyme‐deficient mice are viable despite alterations in lipoprotein metabolism. Proc Natl Acad Sci USA 1996, 93: 7154–7159.Jr , Ng, J, Sande, E, et al. Targeted disruption of the mouse apobec‐1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J Biol Chem 1996, 271: 9887–9890.et al. Complementation of apolipoprotein B mRNA editing by human liver accompanied by secretion of apolipoprotein B48. J Biol Chem 1994, 269: 5932–5936.et al. The apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense‐mediated decay. EMBO J 2003, 22: 3971–3982.2 ): 153–164.et al. Thyroid hormone regulates hepatic triglyceride mobilization and apolipoprotein B messenger ribonucleic acid editing in a murine model of congenital hypothyroidism. Endocrinology 2003, 144: 711–719.et al. Mutational analysis of apolipoprotein B mRNA editing enzyme (APOBEC1). Structure‐function relationships of RNA editing and dimerization. J Lipid Res 1999, 40: 623–635.Pt 5 ): 1027–1039.et al. Extract‐specific heterogeneity in high‐order complexes containing apolipoprotein B mRNA editing activity and RNA‐binding proteins. J Biol Chem 1993, 268: 7382–7392.et al. Novel role for RNA‐binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec‐1 and ACF, the apobec‐1 complementation factor. J Biol Chem 2001, 276: 47338–47351.et al. A DnaJ protein, apobec‐1‐binding protein‐2, modulates apolipoprotein B mRNA editing. J Biol Chem 2001, 276: 46445–46452.et al. Identification of GRY‐RBP as an apolipoprotein B RNA‐binding protein that interacts with both apobec‐1 and apobec‐1 complementation factor to modulate C to U editing. J Biol Chem 2001, 276: 10272–10283.et al. Targeted deletion of the murine apobec‐1 complementation factor (acf) gene results in embryonic lethality. Mol Cell Biol 2005, 25: 7260–7269.et al. C − %3E U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec‐1, the catalytic subunit of the apolipoprotein B mRNA‐editing enzyme. Am J Hum Genet 2002, 70: 38–50.et al. Apobec‐1 protects intestine from radiation injury through posttranscriptional regulation of cyclooxygenase‐2 expression. Gastroenterology 2004, 127: 1139–1149.et al. MiR‐101 downregulation is involved in cyclooxygenase‐2 overexpression in human colon cancer cells. Exp Cell Res 2009, 315: 1439–1447.et al. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase‐2 expression in colon cancer cells. J Clin Invest 2001, 108: 1657–1665.et al. Deletion of the AU‐rich RNA binding protein apobec‐1 reduces intestinal tumor burden in APCmin mice. Cancer Res 2007, 67: 8565–8573.et al. Up‐regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994, 107: 1183–1188.et al. A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low‐fat chow diet. Nat Med 1998, 4: 934–938.−/− Mttp‐IKO mice: a survival advantage for mammalian intestinal apolipoprotein B mRNA editing. J Biol Chem 2007, 282: 33043–33051.et al. Decreased expression of cholesterol 7{alpha}‐hydroxylase and altered bile acid metabolism in Apobec‐1 − /− Mice lead to increased gallstone susceptibility. J Biol Chem 2009, 284: 16860–16871.et al. RNA editing of human microRNAs. Genome biol 2006, 7: R27.et al. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat Struct Mol Biol 2006, 13: 13–21.et al. MicroRNA‐155 is a negative regulator of activation‐induced cytidine deaminase. Immunity 2008, 28: 621–629.et al. Apolipoprotein B mRNA‐editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc Natl Acad Sci USA 1995, 92: 8483–8487.et al. Essential role of NAT1/p97/DAP5 in embryonic differentiation and the retinoic acid pathway. EMBO J 2000, 19: 5533–5541.et al. Gene expression during preimplantation mouse development. Genes Dev 1992, 6: 1190–1201.et al. Functional antagonism between RNA binding proteins HuR and CUGBP2 determines the fate of COX‐2 mRNA translation. Gastroenterology 2007, 132: 1055–1065.
